Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Researchers found four genes that could help diagnose severe alopecia areata early.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

A woman's complete hair loss condition improved after recovering from COVID-19.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Six genetic conditions are often linked to complete scalp hair loss in children.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.